A carregar...
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study
The Evaluating Nilotinib Efficacy and Safety in Clinical Trials as First-Line Treatment (ENEST1st) study included 1089 patients with newly diagnosed chronic myeloid leukemia in chronic phase. The rate of deep molecular response (MR(4) (BCR-ABL1⩽0.01% on the International Scale or undetectable BCR-AB...
Na minha lista:
Publicado no: | Leukemia |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4705425/ https://ncbi.nlm.nih.gov/pubmed/26437782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2015.270 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|